DCZ0415 |
رقم الكتالوجGC39370 |
DCZ0415 ، وهو مثبط قوي لـ TRIP13 ، يضعف إصلاح ربط الأطراف غير المتجانسة ويثبط نشاط NF-Bيحفز DCZ0415 النشاط المضاد للورم النقوي في المختبر وفي الجسم الحي وفي الخلايا الأولية المشتقة من مرضى المايلوما المقاومة للأدوية
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2242470-43-3
Sample solution is provided at 25 µL, 10mM.
DCZ0415, a potent TRIP13 inhibitor, impairs nonhomologous end joining repair and inhibits NF-κB activity. DCZ0415 induces anti-myeloma activity in vitro, in vivo, and in primary cells derived from drug-resistant myeloma patients[1].
[1]. Wang Y, et al. A Small Molecule Inhibitor Targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2019 Nov 15. pii: canres.3987.2018.
Average Rating: 5
(Based on Reviews and 39 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *